Marga J. A. de Graaff-Teulen

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
The aim of this study was to design a parenteral dosage form for the investigational cytotoxic drag carzelesin. A stable formulation in PET (Polyethylene glycol 400/absolute ethanol/Tween 80, 6:3:1, v/v/v) was developed. The prototype, containing 0.50 mg carzelesin in 2.0 ml PET formulation, was found to be the optimal formulation in terms of solubility,(More)
  • 1